COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan

Abstract The immunity of patients who recover from coronavirus disease 2019 (COVID-19) could be long lasting but persist at a lower level. Thus, recovered patients still need to be vaccinated to prevent reinfection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or its mutated varian...

Full description

Bibliographic Details
Main Authors: Hong Liang, Xuanxuan Nian, Junzheng Wu, Dong Liu, Lu Feng, Jia Lu, Yan Peng, Zhijun Zhou, Tao Deng, Jing Liu, Deming Ji, Ran Qiu, Lianzhen Lin, Yan Zeng, Fei Xia, Yong Hu, Taojing Li, Kai Duan, Xinguo Li, Zejun Wang, Yong Zhang, Hang Zhang, Chen Zhu, Shang Wang, Xiao Wu, Xiang Wang, Yuwei Li, Shihe Huang, Min Mao, Huanhuan Guo, Yunkai Yang, Rui Jia, Jingwei Xufang, Xuewei Wang, Shuyan Liang, Zhixin Qiu, Juan Zhang, Yaling Ding, Chunyan Li, Jin Zhang, Daoxing Fu, Yanlin He, Dongbo Zhou, Cesheng Li, Jiayou Zhang, Ding Yu, Xiao-Ming Yang
Format: Article
Language:English
Published: Nature Publishing Group 2022-12-01
Series:Cell Discovery
Online Access:https://doi.org/10.1038/s41421-022-00496-x